{"name": "Holodiag",
 "permalink": "holodiag",
 "crunchbase_url": "http://www.crunchbase.com/company/holodiag",
 "homepage_url": "http://www.holodiag.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "enterprise",
 "number_of_employees": null,
 "founded_year": 2006,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "polymorph-screening, salt-screening, crystallization, solid-state-characterization, pharmaceutical-consulting, enantiomer-separation",
 "alias_list": null,
 "email_address": "contact@holodiag.com",
 "phone_number": "+33232405826",
 "description": "CRO solid state characterization",
 "created_at": "Tue Nov 15 17:47:24 UTC 2011",
 "updated_at": "Mon Nov 21 05:29:53 UTC 2011",
 "overview": "\u003Cp\u003EHolodiag is a CRO with services dedicated to the pharmaceutical solid state. Our services include :\u003C/p\u003E\n\n\u003Cul\u003E\n\u003Cli\u003E\u003Cp\u003ESolid state analyses (X-ray diffraction, DSC, TGA, ..)\u003C/p\u003E\u003C/li\u003E\n\u003Cli\u003E\u003Cp\u003ECrystallization screening (including polymorph screening, salt screening and selection, co-crystal screening, counter-ions, solvents, single crystals, resolving agents)\u003C/p\u003E\u003C/li\u003E\n\u003Cli\u003E\u003Cp\u003EProcess development (selective crystallization of polymorphs, enantiomer separation, purity/yield optimization)\u003C/p\u003E\u003C/li\u003E\n\u003Cli\u003E\u003Cp\u003EPharmaceutical consulting\u003C/p\u003E\u003C/li\u003E\n\u003C/ul\u003E\n\n\u003Cp\u003EWe have a laboratory dedicated to the handling of cytotoxic, CMR and highly potent materials. \u003C/p\u003E\n\n\u003Cp\u003EOur customers like our custom-built services, the elaborated report as well as the scientific and technical support, the swift processing of the analyses (5 worked days) and the expertise of our team.\u003C/p\u003E\n\n\u003Cp\u003EAnalytical Services:\n        X-ray powder diffraction\n        T.G.A.\n        D.S.C.\n        Crystallinity\n        pKa\n        Solubilities\n        Quantification\n        Polymorphic purity\n        Quality control\n        Formulation control\n        Polarimetry\n        Counterfeit analysis\n        More techniques\u003C/p\u003E\n\n\u003Cp\u003EScreening:\n        Salt selection\n        Polymorphism/Solvates\n        Co-crystallization\n        Resolving agents\n        Single crystals\u003C/p\u003E\n\n\u003Cp\u003EHighly Potent:\n    Analytical services\n        Contract research\u003C/p\u003E\n\n\u003Cp\u003ER\u0026amp;D Services:\n        Pharmaceutical development\n        Crystallization\n        Polymorphism\n        Solvates / Hydrates\n        Chiral molecules\n        Scale-up\u003C/p\u003E\n\n\u003Cp\u003EConsulting:\n    Project development\n        Litigation/Expert witness\n        Patent search/ Bibliography\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       42],
      "assets/images/resized/0016/2517/162517v2-max-150x150.jpg"],
     [[200,
       57],
      "assets/images/resized/0016/2517/162517v2-max-250x250.jpg"],
     [[200,
       57],
      "assets/images/resized/0016/2517/162517v2-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CEO",
    "person":
     {"first_name": "Pierric",
      "last_name": "Marchand",
      "permalink": "pierric-marchand",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "Office",
    "address1": "voie de l'Innovation",
    "address2": "Pharmaparc II",
    "zip_code": "27100",
    "city": "Val de Reuil",
    "state_code": null,
    "country_code": "FRA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}